Literature DB >> 24758712

Crystallization of progesterone polymorphs using polymer-induced heteronucleation (PIHn) method.

Andrea Mariela Araya-Sibaja1, Valdir Soldi, Carlos Eduardo Maduro Campos, Simone Gonçalves Cardoso, Silvia Lucia Cuffini.   

Abstract

Progesterone is a natural hormone steroid used in humans for several treatments and in livestock for artificial insemination, which exhibits two polymorphic forms at ambient conditions: form 1 and form 2. Form 2 is metastable and more soluble than form 1; however, it is not suitable to use as powder raw material because it transforms into form 1 by the effects of grinding. A polymorphic screening of progesterone based on polymer-induced heteronucleation method was performed as an alternative to prepare the metastable form. Polyvinyl alcohol, hydroxypropyl methylcellulose (HPMC), dextran, gelatin, polyisoprene (PI) and acrylonitrile-butadiene (NBR) copolymer were used. Crystals were prepared from 0.5, 10 and 40 mg/mL solutions in acetone at room temperature by solvent evaporation. The samples were characterized by X-ray powder diffraction, differential scanning calorimetry (DSC), scanning electron microcopy and attenuated total reflectance infrared Fourier transform spectroscopy. Form 1 was nucleated from 40 mg/mL solutions on the six polymers and from 10 mg/mL solutions on PI and NBR. The mixture of form 1 and form 2 was obtained from 10 mg/mL solution on HPMC, dextran and gelatin and from 0.5 mg/mL solution crystallizations. Therefore, the polymeric devices, which crystallized the metastable and more soluble polymorph (2) of progesterone, would be a promissory alternative for the pharmaceutical applications.

Entities:  

Keywords:  Growth from solutions; polymer templating; polymer-induced heteronucleation; polymorph screening; preferred orientation; progesterone

Mesh:

Substances:

Year:  2014        PMID: 24758712     DOI: 10.3109/03639045.2014.909839

Source DB:  PubMed          Journal:  Drug Dev Ind Pharm        ISSN: 0363-9045            Impact factor:   3.225


  1 in total

1.  Progesterone PLGA/mPEG-PLGA Hybrid Nanoparticle Sustained-Release System by Intramuscular Injection.

Authors:  Bin Xie; Yang Liu; Yuting Guo; Enbo Zhang; Chenguang Pu; Haibing He; Tian Yin; Xing Tang
Journal:  Pharm Res       Date:  2018-02-14       Impact factor: 4.200

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.